A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2

NCT06003231 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung
Ovarian Neoplasms
Endometrial Neoplasms
Head and Neck Neoplasms

Interventions

DRUG: disitamab vedotin

Sponsor

Seagen, a wholly owned subsidiary of Pfizer